Healthcare Services

Cholesterol Test Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

March 31, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Cholesterol Test Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The market for cholesterol tests has demonstrated substantial growth over recent years. This market is projected to expand from $9.94 billion in 2025 to $10.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.7%. Historically, this expansion has been driven by factors such as the increasing incidence of cardiovascular diseases, heightened awareness regarding cholesterol monitoring, the proliferation of diagnostic laboratory networks, an uptick in preventive healthcare screening initiatives, and the widespread availability of cost-effective test kits.

The cholesterol test market is anticipated to experience robust expansion in the coming years. By 2030, this market is projected to reach $15.25 billion, demonstrating a compound annual growth rate (CAGR) of 9.0%. Factors driving this growth over the projected timeframe include a heightened need for self-monitoring diagnostic instruments, an amplified emphasis on early disease diagnosis, the broadening availability of remote patient testing options, the escalating incorporation of digital health platforms, and the wider uptake of personalized healthcare diagnostics. Key trends anticipated during the forecast period encompass a greater acceptance of at-home cholesterol testing kits, a surge in the requirement for point-of-care lipid testing apparatus, an expanding utilization of multi-parameter lipid panels, the scaling up of preventive cardiovascular screening initiatives, and an intensified drive for quick and precise test outcomes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11968&type=smp

What Major Drivers Are Influencing Demand In The Cholesterol Test Market?

The increasing prevalence of cardiovascular diseases is anticipated to fuel the expansion of the cholesterol test market. Cardiovascular diseases (CVDs) refer to a range of disorders affecting the heart and blood vessels, including coronary heart disease, stroke, peripheral arterial disease, aortic disease, and similar conditions. A cholesterol test furnishes individuals and physicians with essential insights concerning the risk of developing heart disease. For example, in August 2025, the National Institutes of Health, a US-based government entity, reported that from 2025 to 2050, cardiovascular prevalence is forecast to surge by 90%, mortality by 73%, and DALYs by 55%, with fatalities increasing from 20.5 million to 35.6 million. Thus, the escalating prevalence and mortality associated with cardiovascular diseases will propel the cholesterol test market.

What Major Segment Divisions Exist Within The Cholesterol Test Market?

The cholesterol test market covered in this report is segmented –

1) By Product Type: Test Kits, Test Strips, Other Product Types

2) By Test Type: Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Triglycerides Or Very Low-Density Lipoprotein (VLDL) Cholesterol Test

3) By Distribution Channel: Over The Counter, Prescription Based

4) By End User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By Test Kits: Home Testing Kits, Laboratory Testing Kits

2) By Test Strips: Disposable Test Strips, Multi-Use Test Strips

3) By Other Product Types: Point-Of-Care Testing Devices, Cholesterol Monitors, Reagents And Calibration Solutions

What Major Market Trends Are Driving Changes In The Cholesterol Test Market?

Major entities within the cholesterol test market are channeling their efforts into developing innovative solutions, such as advanced blood testing systems. These aim to bolster the early detection and ongoing monitoring of cholesterol levels, thereby enhancing patient outcomes, facilitating personalized treatment plans, and backing preventive health initiatives. A blood testing system constitutes a comprehensive framework or platform utilized for scrutinizing blood samples to identify various components, markers, or conditions. As an illustration, in March 2024, Babson Diagnostics, Inc., a healthcare technology startup located in Austrelia, unveiled the BetterWay system. This innovative blood testing solution incorporates the MiniDraw device for collecting samples from a fingertip. The system operates by warming the patient’s hand, obtaining a pea-sized blood sample with a lancet-equipped device, and then automating sample preparation, which encompasses mixing and temperature control, before the sample is dispatched to Babson’s lab for examination. BetterWay can assess cholesterol, blood cell counts, and the function of the liver, kidneys, and thyroid from a minimal blood volume, furnishing results within one to two days, all while boosting patient comfort and convenience. This method effectively closes the divide between conventional laboratory-based testing and point-of-care accessibility, thereby refining routine cholesterol surveillance.

Which Companies Are Leading Innovation In The Cholesterol Test Market?

Major companies operating in the cholesterol test market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, CVS Health Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, Diazyme Laboratories Inc.

Read the full cholesterol test market report here:

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Cholesterol Test Market?

North America was the largest region in the cholesterol test market in 2025. The regions covered in the cholesterol test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cholesterol Test Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11968&type=smp

Browse Through More Reports Similar to the Global Cholesterol Test Market 2026, By The Business Research Company

Pruritus Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Pompe Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/pompe-disease-global-market-report

Hidradenitis Suppurativa Global Market Report

https://www.thebusinessresearchcompany.com/report/hidradenitis-suppurativa-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795